Free Trial

Evelo Biosciences (EVLO) Competitors

Evelo Biosciences logo
$0.0005 0.00 (0.00%)
As of 06/30/2025

EVLO vs. NAVB, SCPS, CMRA, GNCAQ, GNCA, ARDS, STAB, AMPE, CLVR, and EFTR

Should you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Navidea Biopharmaceuticals (NAVB), Scopus BioPharma (SCPS), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), Clever Leaves (CLVR), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry.

Evelo Biosciences vs. Its Competitors

Evelo Biosciences (NASDAQ:EVLO) and Navidea Biopharmaceuticals (NYSE:NAVB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Evelo Biosciences has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Navidea Biopharmaceuticals has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
Evelo BiosciencesN/A N/A N/A
Navidea Biopharmaceuticals N/A N/A N/A

0.3% of Evelo Biosciences shares are owned by institutional investors. Comparatively, 0.0% of Navidea Biopharmaceuticals shares are owned by institutional investors. 1.0% of Evelo Biosciences shares are owned by insiders. Comparatively, 43.7% of Navidea Biopharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Evelo Biosciences had 2 more articles in the media than Navidea Biopharmaceuticals. MarketBeat recorded 2 mentions for Evelo Biosciences and 0 mentions for Navidea Biopharmaceuticals. Evelo Biosciences' average media sentiment score of 0.32 beat Navidea Biopharmaceuticals' score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Evelo Biosciences Neutral
Navidea Biopharmaceuticals Neutral

Navidea Biopharmaceuticals has higher revenue and earnings than Evelo Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evelo BiosciencesN/AN/A-$114.53MN/AN/A
Navidea Biopharmaceuticals$8.13K12.32-$15.18MN/AN/A

Summary

Navidea Biopharmaceuticals beats Evelo Biosciences on 4 of the 7 factors compared between the two stocks.

Get Evelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVLO vs. The Competition

MetricEvelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$9K$766.95M$5.48B$8.94B
Dividend YieldN/A4.84%5.38%4.12%
P/E RatioN/A1.0726.2219.74
Price / SalesN/A218.86394.92109.12
Price / CashN/A23.4436.4957.06
Price / BookN/A5.887.915.37
Net Income-$114.53M-$27.56M$3.15B$248.34M
7 Day PerformanceN/A-0.96%0.75%1.67%
1 Month PerformanceN/A6.05%3.46%4.56%
1 Year PerformanceN/A9.13%34.60%18.42%

Evelo Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120Upcoming Earnings
NAVB
Navidea Biopharmaceuticals
N/A$0.00
flat
N/A+100.0%$20K$8.13K0.0010
SCPS
Scopus BioPharma
N/A$0.00
-97.0%
N/AN/A$13KN/A0.009Gap Down
CMRA
Comera Life Sciences
N/A$0.00
flat
N/A-99.2%$6K$1.00M0.002
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/A-99.8%$5K$3.09M0.0030
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020
AMPE
Ampio Pharmaceuticals
0.1481 of 5 stars
$0.00
flat
N/A-99.9%$3KN/A0.0020Gap Down
CLVR
Clever Leaves
N/A$0.00
flat
N/A-100.0%$1K$17.42M0.00560
EFTR
eFFECTOR Therapeutics
N/A$0.00
flat
N/A-99.9%$1K$3.55M0.0010

Related Companies and Tools


This page (NASDAQ:EVLO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners